NurrOn Pharmaceuticals

Manufacturing · 11-50 Employees

View Company Info for Free

Overview

Phone Number

(781) 608-8144

Website

www.nurronpharma.com

Revenue

$9.4 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development

About NurrOn Pharmaceuticals

NurrOn Pharmaceuticals is a clinical-stage biopharmaceutical company based in Boston, USA, focused on developing innovative, disease-modifying therapies for Parkinson's disease and other Nurr1-related disorders. The company aims to enhance the quality of life for Parkinson's patients by creating targeted therapeutics that maximize efficacy while minimizing side effects. NurrOn's approach involves targeting Nurr1, a key regulator in dopaminergic neuron development, to slow or prevent disease progression. Their research includes both monotherapy and combination treatment strategies to improve clinical outcomes for patients.Explore more
SIC Code 28,283NAICS Code 32,325Show more

NurrOn Pharmaceuticals Org Chart

DK
Deog Kim

Chief Executive Officer

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email
TW
Thomas Wessel

Chief Marketing Officer, Acting, Nurron Pharm...

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to NurrOn Pharmaceuticals

Compare insights from companies similar to NurrOn Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

NurrOn Pharmaceuticals

$9.4M
11-50
Private
-
2009
DK
Deog KimCEO
KLUS Pharma
$7.8M
11-50
Private
-
2014
HT
Haijun TianSenior VP & Head of Site (US)
P2D Bioscience
<$5M
1-10
Private
-
2004
PG
Prasad GabbitaCEO
SFA Therapeutics
<$5M
1-10
Private
<$5M
2017
JK
James KirwinChief Operating Officer & Senior VP, Clinical Development
Illustration of an envelope

NurrOn Pharmaceuticals Tech Stack

A closer look at the technologies used by NurrOn Pharmaceuticals

GoCentral

By

GoDaddy
YouTube

By

Google
GoDaddy DNS

By

GoDaddy
Amazon Web Hosting

By

Amazon Web Services
See more technologies

Top Manufacturing Companies

Top companies in Canada by revenue

I-MED Pharma
Merz Pharma Canada
Ceva
Bausch & Lomb
Bausch Health, Canada
View Full List

Top companies in Australia by revenue

De Motu Cordis
Orion Pharma
Generic Health
Contract Pharmaceutical Services of Australia
Biorevive
View Full List

Top companies in New Zealand by revenue

AFT Pharmaceuticals
Novo Nordisk Group of Companies
AbbVie New Zealand
Glycosyn
API Consumer Brands
View Full List
See more top companies

Frequently Asked Questions Regarding NurrOn Pharmaceuticals

What is NurrOn Pharmaceuticals's official website?
NurrOn Pharmaceuticals's official website is www.nurronpharma.com What is NurrOn Pharmaceuticals's Revenue?
NurrOn Pharmaceuticals's revenue is $9.4 Million What is NurrOn Pharmaceuticals's SIC code?
NurrOn Pharmaceuticals's SIC: 28,283 What is NurrOn Pharmaceuticals's NAICS code?
NurrOn Pharmaceuticals's NAICS: 32,325 How many employees does NurrOn Pharmaceuticals have?
NurrOn Pharmaceuticals has 11-50 employees What industry does NurrOn Pharmaceuticals belong to?
NurrOn Pharmaceuticals is in the industry of: Manufacturing, Pharmaceuticals, Business Services What is NurrOn Pharmaceuticals competition?
NurrOn Pharmaceuticals top competitors include: P2D Bioscience, SFA Therapeutics, KLUS Pharma What technology does NurrOn Pharmaceuticals use?
Some of the popular technologies that NurrOn Pharmaceuticals uses are: GoCentral, YouTube, GoDaddy DNS, Amazon Web Hosting How do I contact NurrOn Pharmaceuticals?
NurrOn Pharmaceuticals contact info: Phone number: (781) 608-8144 Website: www.nurronpharma.com What does NurrOn Pharmaceuticals do?

NurrOn Pharmaceuticals is a clinical-stage biopharmaceutical company based in Boston, USA, focused on developing innovative, disease-modifying therapies for Parkinson's disease and other Nurr1-related disorders. The company aims to enhance the quality of life for Parkinson's patients by creating targeted therapeutics that maximize efficacy while mi... nimizing side effects. NurrOn's approach involves targeting Nurr1, a key regulator in dopaminergic neuron development, to slow or prevent disease progression. Their research includes both monotherapy and combination treatment strategies to improve clinical outcomes for patients.Read More

 Is NurrOn Pharmaceuticals a public company?
NurrOn Pharmaceuticals is private company therefore does not currently have an official ticker symbol
See more information about NurrOn Pharmaceuticals

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.

Test Drive ZoomInfo's Directories

Browse Directories

Most Searched Industries

Construction Law Firms & Legal Services Business Services Finance Manufacturing Agriculture Software Accounting & Accounting Services Retail Healthcare Energy, Utilities & Waste Treatment Telecommunications Transportation Real Estate
People SearchCompany Search